AI in everyday life and in the regulators' spotlight
Life science today is deeply intertwined with data-driven technologies. Machine learning is used to predict treatment outcomes, AI optimizes the design of clinical trials, and in drug development, huge amounts of data are analyzed to identify new molecular connections.
But with increased influence comes increased responsibility. The AI Regulation targets precisely these applications, especially when AI systems influence medical decisions or product quality. They are often classified as "high risk," which triggers extensive requirements for documentation, monitoring, transparency, and explainability.
The AI Regulation clarifies what more and more regulatory frameworks are moving towards: that responsible technology requires transparency in both results and processes. It is not enough to assess what an AI model does; we must also understand how it got there. What data has been used? How is the model trained? And how do we enable review, traceability, and explainability throughout the entire life cycle? These types of requirements drive the maturity of how we relate to AI, both technically, ethically, and organizationally.
From list of requirements to competitive advantage
Compliance is often seen as an obligation. But for organizations that already invest in model governance, data quality, and explainability—not because they have to, but because they recognize the business value—compliance becomes something more. A framework that not only ensures compliance, but actively builds trust, robustness, and innovation. This creates an opportunity to turn compliance into a clear competitive advantage.
Being able to demonstrate that an AI system not only works, but works in a robust, transparent, and predictable way is becoming increasingly important, even for partners, investors, and healthcare providers. Trust is becoming a strategic resource. And it is not built after the fact, but throughout the entire life cycle.
There is a clear value here: players who incorporate the requirements of the regulation as an integral part of their development process, rather than as a "compliance phase" at the end, are better equipped to scale up, establish partnerships, and obtain regulatory approval in multiple markets. It becomes a mark of quality rather than an obstacle.
Regulations meet reality
It is easy to view the AI Regulation as yet another framework to navigate, alongside the MDR, IVDR, GxP, and the General Data Protection Regulation. But it also reflects something bigger: society's growing demand for responsible technology.
In practice, this means a new design logic. Systems should not only deliver correct decisions, but also be able to explain how they arrived at them. Black box models are becoming less and less acceptable. Instead, there are increasing demands for explainability, traceability, and human oversight.
För organisationer inom life science innebär det ett behov av att omforma inte bara tekniken, utan processerna runt den. AI-projekt måste integreras med kvalitetsledningssystem. Data måste hanteras med högre grad av validering, versionering och kontextuell förståelse.
This is not a quick fix, but neither is it uncharted territory. Life science is one of the few industries with proven experience of working in a structured manner with quality and safety in complex systems. This is an advantage that can be built upon.
Lead, don't follow
The most successful players in life sciences are rarely those who simply adapt to new regulations, but rather those who use the regulations to shape their strategic direction.
With the AI Regulation, this can be expressed in concrete terms in how organizations work with AI governance: establishing governing principles for everything from model development to risk assessment, monitoring, and reporting. But also in how to engage in regulatory sandboxes, industry-wide initiatives, and standardization work.
Companies that dare to think iteratively and adaptively about compliance, building in the ability to grow with the regulatory framework, will be stronger. This is especially true when AI solutions move from pilot to production environments, or when collaboration across organizational boundaries is required.
The great opportunity is therefore not to follow the rules, but to shape your own future based on them.
Start here
1. Map your AI applications and assess the level of risk
Start by identifying where and how AI is used in your business. Is it for product development, manufacturing optimization, diagnostics, or decision support?
Assess whether the application falls within the definitions of the AI Regulation, especially if it risks being classified as "high risk." Most importantly, ensure that it does not fall under prohibited AI use cases.
Tip: Use the AI Regulation's risk classification as a basis, but combine it with internal risk assessment to obtain a nuanced picture.
2. Establish AI governance that can grow with the technology
Create an internal structure for governance, accountability, and documentation of AI models. This includes roles for model owners, reviewers, and decision-making functions.
Tip: Integrate AI governance into existing quality management systems rather than building parallel tracks. This will make it scalable, traceable, and tailored to your regulatory needs.
3. Prioritize transparency and explainability from the outset
The regulation requires AI systems, especially high-risk ones, to be explainable. This means not only that "it works," but that it is possible to show how and why a decision was made.
Tip: Invest early in incorporating risk management, change management, explainability, versioning, logging, and decision explanations, etc., which run throughout the entire lifecycle.
4. Collaborate: regulatory sandboxes & industry initiatives
The EU and several member states are currently developing regulatory sandboxes for AI, which are controlled environments where organizations can test and validate their systems in dialogue with supervisory authorities. This not only provides practical insight into how the law is applied, but also creates opportunities to influence how interpretations and standards are shaped in practice.
Tip: Join industry groups, research consortia, or pilot collaborations. This will give you both insights and influence.
5. View compliance as a strategic tool
Instead of viewing AI regulation as an obstacle, use it as an argument. To show that your AI is robust, responsible, and ready for the future. This builds trust, both with regulators and business partners.
Tip: Use your work with the regulation as part of your external communication: show that you take responsibility for the technology you develop or use.
6. Get help and support
The AI Regulation straddles the boundaries between technology, law, quality, and ethics. For many organizations, this is a complex landscape to navigate, especially in an industry where standards are already high. Building the right structure from the outset can save both time and resources down the line.
Tip: Seek support from experts who understand both regulatory requirements and the life science environment. We work at the intersection where technology, quality, and business meet. Together, we will continue the dialogue to find the right steps and path for you.
